I'd Put $2,500 Into Each of These 4 Dividend Stocks and Delete the App These four dividend stocks have earned something rare: the right to be bought, held, and genuinely forgotten about for a while.
4 Medicare Changes Coming Your Way in 2027 It's worth reviewing these before you make any changes to your Medicare coverage for next year.
Forget the COLA. Here's the Social Security Increase You Should Care About. Many seniors focus on the COLA, but there's another increase that will make a bigger difference for their finances.
Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally XLU bounced off a 52-week low near $39 as rising Treasury yields pressured utilities; NextEra Energy and Southern Company, its top holdings, show signs of a sector bottom forming.
Stock Market Pattern Echoes the Dot-Com Era and History Points to 1 Move Investors Should Make Now The S&P 500 is trading at valuation levels last seen before the dot-com bubble, with a disconnect between new highs and new lows.
Is Rocket Companies (RKT) Stock a Buy, Sell, or Hold Near Its 52-Week Low? Rocket Companies is becoming a real-estate powerhouse, and its shares seem undervalued.
Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next AI-driven demand is lifting earnings estimates and price targets across cybersecurity, semiconductor, and CPU stocks, including PANW, MRVL, AMD, and INTC, ahead of Q3 results.
Here's Where These 4 Nuclear Reactor Stocks Could Be in 5 Years Four nuclear reactor stocks could look very different by 2031, as progress in reactors, revenue growth, and valuations determine shareholder returns.
SpaceX Is Public. Here's What $1,000 in Each of These 5 Space Stocks Could Be Worth by 2030. Space industry experts see this business growing 18% annually over the next five years. Here's what that implies for space stock valuations.
Why Wall Street Expects Even More From SanDisk After Its 575% Rally SanDisk shares have surged 575% in 2026 on AI storage demand, and analysts including Mizuho, Rosenblatt, and Arete Research keep raising price targets ahead of earnings later this month.
Is Oklo the Next Trillion-Dollar Stock? Could Oklo be the first nuclear company to join the trillion-dollar club?
The Grocery Shelf Battle Is Changing—Who Comes Out Ahead? Store brands are gaining unit share over national labels like McCormick as shoppers seek value, while Kroger and Walmart expand private-label lines to capture margin growth.
Prediction: Netflix Stock Is Going to Soar After Oct. 20 Netflix stock looks incredibly cheap heading into its third-quarter earnings report.
4 Vanguard Funds Worth Buying and Holding for the Next 20 Years Tech and AI have dominated the past several years. The next couple of decades could look a lot different.
Better Cryptocurrency to Buy Now With $1,000: Chainlink vs. XRP One of these coins has a fit with its market, and the other hasn't yet found one.
Schwab's Dividend ETF's Worst Year Since 2012 Was a 5.5% Loss. The Cost Showed Up in the Good Years. Its worst calendar year since 2012 was a loss of around 5.5%. What has that steadiness cost in the good years?
Meet the Only AI Stock I'd Buy Over Nvidia in October ASML is thinking years ahead of the AI industry, ensuring it remains an industry leader well into the 2030s.
1 Reason to Buy Carnival Stock (CCL) in October The leading cruise line operator posted all-time-high metrics across the board in Q3.
3 Surging Cryptocurrencies to Buy Now and Hold for 5 Years or More These three coins are positioned to be valuable crypto infrastructure, and they're all gaining traction.
Alphabet Is the Robotaxi Stock to Buy as Waymo Chases 1 Million Rides a Week The robotaxi leader's just halfway to its year-end target. Does the stock need it to get there?
As GLP-1 Drugs Change How People Eat, Drugmakers Collect and Snack Makers Feel the Squeeze The weight-loss drugs are growing in popularity and altering consumer behavior in significant ways.
Costco Stock Is 14% Below Its Record. History Says Buyers Have Usually Been Rewarded. Past dips in the warehouse club's shares have mostly paid off. Does a better September make this one worth buying?
Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. FDA approval will help, as will insurer adoption of Galleri, but the price that they might be willing to pay for the test is also critical.
History Says This 1 ETF Could Turn $1,000 Into $38,000 in 20 Years. Here's How. If it grows at the rate it's grown over the past three years, your stake could end up worth over $400,000! (But closer to $38,000 is more likely.)
TSMC Reports Oct. 15. It's the Best Early Read on Nvidia's Next Quarter. The AI chip giant won't report for weeks. What can its chipmaker's results show investors first?
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
Atour's 2026 Outlook: Asset-Light Expansion Scales Hotel Network to 2,175 Locations This under-the-radar hospitality stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
